AR013149A1 - Derivados de (1h-imidazol-4-il)piperidina, su preparacion y su aplicacion en terapeutica - Google Patents

Derivados de (1h-imidazol-4-il)piperidina, su preparacion y su aplicacion en terapeutica

Info

Publication number
AR013149A1
AR013149A1 ARP980103161A ARP980103161A AR013149A1 AR 013149 A1 AR013149 A1 AR 013149A1 AR P980103161 A ARP980103161 A AR P980103161A AR P980103161 A ARP980103161 A AR P980103161A AR 013149 A1 AR013149 A1 AR 013149A1
Authority
AR
Argentina
Prior art keywords
alkyl group
group
linear
branched
phenyl
Prior art date
Application number
ARP980103161A
Other languages
English (en)
Spanish (es)
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo filed Critical Synthelabo
Publication of AR013149A1 publication Critical patent/AR013149A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ARP980103161A 1997-07-01 1998-06-30 Derivados de (1h-imidazol-4-il)piperidina, su preparacion y su aplicacion en terapeutica AR013149A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9708256A FR2765580B1 (fr) 1997-07-01 1997-07-01 Derives de (1h-imidazol-4-yl)piperidine, leur preparation et leur application en therapeutique

Publications (1)

Publication Number Publication Date
AR013149A1 true AR013149A1 (es) 2000-12-13

Family

ID=9508676

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP980103161A AR013149A1 (es) 1997-07-01 1998-06-30 Derivados de (1h-imidazol-4-il)piperidina, su preparacion y su aplicacion en terapeutica

Country Status (7)

Country Link
EP (1) EP0994857A1 (fr)
JP (1) JP2002507983A (fr)
AR (1) AR013149A1 (fr)
AU (1) AU8220598A (fr)
FR (1) FR2765580B1 (fr)
WO (1) WO1999001435A1 (fr)
ZA (1) ZA985727B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6887870B1 (en) 1999-10-12 2005-05-03 Bristol-Myers Squibb Company Heterocyclic sodium/proton exchange inhibitors and method
GB0011089D0 (en) * 2000-05-08 2000-06-28 Black James Foundation Gastrin and cholecystokinin receptor ligands (11)
TW200614995A (en) 2004-11-10 2006-05-16 Nicholas Piramal India Ltd Tricyclic guanidine derivatives as sodium-proton exchange inhibitors

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4357341A (en) * 1981-05-22 1982-11-02 The United States Of America As Represented By The Department Of Health And Human Services Specific irreversible antagonism of histamine receptors by photoaffinity actuated compounds
FR2674855B1 (fr) * 1991-04-03 1994-01-14 Synthelabo Derives de piperidine, leur preparation et leur application en therapeutique.

Also Published As

Publication number Publication date
EP0994857A1 (fr) 2000-04-26
WO1999001435A1 (fr) 1999-01-14
JP2002507983A (ja) 2002-03-12
FR2765580B1 (fr) 1999-08-06
AU8220598A (en) 1999-01-25
ZA985727B (en) 1999-01-27
FR2765580A1 (fr) 1999-01-08

Similar Documents

Publication Publication Date Title
FI862757A (fi) Pyridonkarbonsyraderivat och foerfarande foer framstaellning av dessa.
SE8701348D0 (sv) Improvements in pharmaceutically acceptable salts
NO20056007L (no) Dobbel NK1/NK3 antagonister for behandling av schizofreni
DK1224940T4 (da) Flydende formuleringer af interferon-beta
CR8735A (es) Derivados de tetrahidroisoquinolinilsulfonamidas, su preparacion y su utilizacion en terapeutica
ATE175661T1 (de) Benzamid-derivate als vasopressin-antagonisten
ES2056783T3 (es) Derivados sustituidos del acido benzoico con actividad cardiovascular.
ES465528A1 (es) Procedimiento para la obtencion de nuevas feniletilaminas.
EA200200489A1 (ru) Новые соединения бензотиадиазина, способ их получения и содержащие их фармацевтические композиции
AR013149A1 (es) Derivados de (1h-imidazol-4-il)piperidina, su preparacion y su aplicacion en terapeutica
ES2063471T3 (es) Nuevos derivados de guanidina, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
DE69103968D1 (de) 2-(Aminoalkyl)-5-(arylalkyl)1,3-dioxanderivate, ihre Herstellung und ihre Anwendung in der Therapeutik.
AR013241A1 (es) Derivados del acido aminoetilfenoxiacetico, composicion farmaceutica que incluye a dicho derivado, medicamento para reducir el dolor y promover la eliminacion de calculos en urolitiasis, utilizacion de dicho derivado para la fabricacion de dicha composicion farmaceutica y procedimiento para la fabri
HRP20010630B1 (en) 4-heterocyclysulfonamidyl-6-methoxy-5-(2-methoxy-phenoxy)-2-pyridyl-pyrimidine derivatives, their preparation and use as endothelin receptor antagonists
CO4940417A1 (es) DERIVADOS DE 2,3-DIHIDROFURO[3,2-b]PIRIDINA, SU PREPARACION Y SU APLICACION EN TERAPEUTICA
IT1191845B (it) Alchiloli derivati farmacologicamente attivi
MA32036B1 (fr) Composés de n-phenyl-imidazo[1,2-a]pyridine-2-carboxamides, leur préparation et leur application en thérapeutique
DK390384A (da) Midler med antimikrobiel virkning indeholdende derivater af benzoesyre og deres anvendelse som desinficerende laegemidler eller konserveringsmidler
CO4750816A1 (es) Derivados de bencenosulfonamida, su preparacion y su aplicacion en terapeutica
DK599486A (da) 1,4-dihydropyridiner, deres fremstilling af anvendelse som laegemidler
DE60112917D1 (de) Neue polyzyklische indanylimidazole mit alpha2 adrenergik aktivität
ATE45575T1 (de) Prostacycline.
DE69730232D1 (de) Arylphtalazine antagonisten vonexitatonischen amino saüre rezeptoren
AR023528A1 (es) Derivados de ciclobuten-3,4-diona, su preparacion y su aplicacion en terapeutica
AR023548A1 (es) Derivados de 2-alcoxi-ciclobuten-3,4-diona, su preparacion y su aplicacion en terapeutica